Care Consideration: Guideline Updates

ICARE Newsletter Fall 2026

New ESMO Recommendations About Genetic Testing

The European Society of Medical Oncology (ESMO) evaluated breast cancer susceptibility genes on the basis of cancer-related mortality to help guide which genes should be included in genetic testing for inherited breast cancer. They indicated that those that may lead to patients living longer included: BRCA1, BRCA2, PALB2, RAD51C, RAD51D, TP53 (for breast cancer diagnosed …

Continue reading

Permanent link to this article: https://inheritedcancer.net/nlf202611/

ICARE Newsletter Fall 2026

National Comprehensive Cancer Network (NCCN) Guidelines Update: Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric (Version 1.2026)

The panel set a specific minimal set of genes to test for colorectal, endometrial, and gastric cancer: COLORECTAL CANCER GENES(including genes that predispose to polyps) Additional genes that sometimes get included: ATM, BLM, CHEK2, GALNT12, RNF43, and RPS20. ENDOMETRIAL (UTERINE) CANCER GENES GASTRIC CANCER GENES Test selection and decision to retest including additional genes beyond these …

Continue reading

Permanent link to this article: https://inheritedcancer.net/nlf20262/

ICARE Newsletter Fall 2026

National Comprehensive Cancer Network (NCCN) Guidelines Update: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2027)

GENE TABLES EXPANDED GENETIC TESTING Testing may be appropriate for some individuals with a close family member who meets testing criteria but has not had genetic testing. This helps expand access to testing for families seeking answers (CRIT-2 & 6), while acknowledging that testing the affected family member is most informative (CRIT-2, 4, 6A, 7, …

Continue reading

Permanent link to this article: https://inheritedcancer.net/nlf20261/

ICARE Social Media Post August 2026

NCCN Breast, Ovarian, Pancreatic, and Prostate Cancer Guidelines Update (Version 1.2027)

New NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Cancer Guidelines (Version 1.2027) were just released on August 31st, 2026! Updates were made to the PRINCIPLES section, testing criteria, and management. To access these new guidelines, create a free account at NCCN.org and visit the following link: https://www.nccn.org/professionals/physician_gls/pdf/genetics_bopp.pdf Through ICARE, we aspire to share …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post83126/

ICARE Newsletter Spring 2026

Introducing the NCCN Guidelines Navigatorโ„ข

Explore this new interactive, color-coded platform designed to simplify navigation of NCCN’s Genetics/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate cancer guidelines. Whether you’re a clinician, researcher, or advocate, this tool helps you stay informed and make confident decisions in cancer care. To read more, create a FREE account at: https://www.nccn.org/guidelines/nccn-guidelines-navigator

Permanent link to this article: https://inheritedcancer.net/nls20262/

ICARE Newsletter Spring 2026

National Comprehensive Cancer Network (NCCN) Guideline Update Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate

Select updates are outlined below. Check out the full guidelines by creating a FREE account at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_bopp.pdf Version 2.2026 focused on adding comprehensive prostate cancer information and revising the name of the guidelines to encompass prostate cancer. Updates included: Version 3.2026 encompassed updates to the discussion section.

Permanent link to this article: https://inheritedcancer.net/nfs20263/

ICARE Social Media Post October 2025

NCCN Breast, Ovarian, Pancreatic, and Prostate Cancer Guidelines Update (V2.2026)

The National Comprehensive Cancer Network (NCCN) just released updated Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Cancer guidelines (Version 2.2026) today! Check out the full guidelines by creating a FREE account at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_bopp.pdf

Permanent link to this article: https://inheritedcancer.net/post10102025/

ICARE Social Media Post October 2025

NCCN Guideline Update: HOXB13

The National Comprehensive Cancer Network (NCCN) released updated prostate cancer guideline for HOXB13 in the new Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Cancer guidelines (Version 2.2026) published today! Check out the full guidelines by creating a FREE account at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_bopp.pdf

Permanent link to this article: https://inheritedcancer.net/post10102025-2/

ICARE Social Media Post October 2025

NCCN CEG Guidelines (V1.2025): TP53 Post

The National Comprehensive Cancer Network (NCCN) just released updated Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Gastric Cancer guidelines on June 13th, 2025 (Version 1.2025). Included in these new guidelines are updates to the TP53 content as follows: To read more, check out the full guidelines by creating a FREE account at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_ceg.pdf

Permanent link to this article: https://inheritedcancer.net/post10062025/

ICARE Social Media Post September 2025

NCCN CEG Guidelines (V1.2025): PMS2 Post

The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Gastric Cancer guidelines on June 13th, 2025 (Version 1.2025). Included in these new guidelines are updates to the surgical options for Lynch carriers and updates to the PMS2 content as outlined below: To read more, check out the full guidelines by creating …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post09152025/

ICARE Social Media Post September 2025

NCCN CEG Guidelines (V1.2025): EPCAM Post

The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Gastric Cancer guidelines on June 13th, 2025 (Version 1.2025). Included in these new guidelines are updates to the surgical options for Lynch carriers and updates to the EPCAM content as outlined below: LS-C 1 of 5 (Page 50) LS-C 5 of 5 …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post09062025/

ICARE Social Media Post September 2025

New MEN1 Guidelines

Learn more by reading the full article at: https://pubmed.ncbi.nlm.nih.gov/40232217/ Reference: Rivero, et al. Endocr Pract. 2025:S1530-891X(25)00038-2. PMID: 40232217.

Permanent link to this article: https://inheritedcancer.net/post09022025/

ICARE Social Media Post Month Year

NCCN CEG Guidelines (V1.2025): NTHL1 Post

The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Gastric Cancer guidelines on June 13th, 2025 (Version 1.2025). Included in these new guidelines are updates to the NTHL1 content. To read more, check out the full guidelines by creating a FREE account at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_ceg.pdf

Permanent link to this article: https://inheritedcancer.net/post080425/

ICARE Social Media Post July 2025

NCCN CEG Guidelines (V1.2025): STK11 Post

The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Gastric Cancer guidelines on June 13th, 2025 (Version 1.2025). Included in these new guidelines are updates to the Peutz-Jeghers Syndrome (PJS) content. To learn more, check out the full guidelines by creating a FREE account at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_ceg.pdf

Permanent link to this article: https://inheritedcancer.net/post072525/

ICARE Social Media Post Month Year

NCCN Colorectal, Endometrial, and Gastric Cancer Guidelines Update (V1.2025)

The National Comprehensive Cancer Network (NCCN) just released updated Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Gastric Cancer guidelines on June 13th, 2025 (Version 1.2025). There are many updates found in these new guidelines including updates to MSH2, EPCAM, PMS2, CDH1, NTHL1, and TP53 content as well as updates to the clinical diagnostic criteria for Peutz-Jeghers Syndrome. …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post071425/

ICARE Social Media Post September 2024

NCCN Breast, Ovarian, and Pancreatic Cancer Guidelines Update

The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Cancer guidelines on September 11th, 2024. Some updates include โคธ To read more, you can check out the full guidelines by creating a FREE account at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf

Permanent link to this article: https://inheritedcancer.net/post91224/